IMPORTANT update: Solutions to Live Despite the mRNA Genocide, New Oxidative Therapies w/ Dr Nieusma

Dr. Joe Nieusma rejoins the program to discuss updates to the Solutions Document for mRNA victims and those subjected to the shedding (which is most of us). We discuss the current die off and the disturbing numbers highlighting the seriousness of the issue. We also discuss the new and promising solutions for you and your loved ones to stay alive and to thrive through this nightmare. You can reach Dr. Joe Nieusma at SuperiorToxicology.com See Solutions to keep from getting sick and to reverse mRNA damage - Dr. Joe Nieusma Support the show by signing up SarahWestall.TV or Ebener (what is Ebener??)! Sign up at SarahWestall.com/Subscribe C60Complete Black Seed Oil & Curcumin Gel Capsules - World Best Immunity Builder! Censorship is serious. To stay informed of all the latest episodes, sign up for my weekly newsletter @ SarahWestall.com/Subscribe Learn more or get your bottle of Z-Stack, Dr. Zelenko's Vitamin Pack specifically for building your immune system and protecting you from getting sick (a weapon to protect you from the "vaccine" weapon): Get Z-Stack Now MUSIC CREDITS: Motivation Underscore by Media Music Group & "Do You Trust Me" by Michael Vignola, licensed for broad internet media use, including video and audio       See on Bastyon| Bitchute | Odysee | Rumble | Freedom.Social | SarahWestall.TV   Dr. Joe Nieusma Biography Dr. Joe Nieusma is our fearless CEO/Chief Toxicologist here at Superior Toxicology & Wellness, an international scientific consulting firm that he founded. Dr. Nieusma is also a co-founder for TwinOxide North America, a company working to improve water quality in all aspects of life from municipal treatment plants to livestock operations. TwinOxide removes all carcinogens from treated water and is the right thing to do. Dr. Nieusma is a member of the Scientific Advisory Board for Vitro Biopharma, a firm that brings new stem-cell related products for diabetes research to scientific, pharmaceutical, and ultimately medical markets.  Dr. Nieusma